Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven(®))

BACKGROUND: A range of plasma volume expanders is used clinically, often in settings where haemostasis may already be impaired. The haemostatic agent, recombinant activated factor VII (rFVIIa, NovoSeven(®)), may be used to improve haemostasis but potential interactions with different volume expander...

Descripción completa

Detalles Bibliográficos
Autores principales: Viuff, D., Lauritzen, B., Pusateri, A. E., Andersen, S., Rojkjaer, R., Johansson, P. I.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
Cardiovascular
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2517151/
https://www.ncbi.nlm.nih.gov/pubmed/18565966
http://dx.doi.org/10.1093/bja/aen175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2517151/
https://www.ncbi.nlm.nih.gov/pubmed/18565966
http://dx.doi.org/10.1093/bja/aen175

Ejemplares similares